Ziftomenib
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 2134675-36-6 |
|---|---|
| INCI Name | 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]-1-[(2S)-2-(4-methylsulfonylpiperazin-1-yl)propyl]indole-2-carbonitrile |
| PubChem CID | 138497449 |
| Molecular Formula | C33H42F3N9O2S2 |
| InChIKey | InChI=1S/C33H42F3N9O2S2/c1- |
| SMILES | CC1=C(C=CC2=C1C=C(N2C[C@H](C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F |
Known Aliases (9)
Common Name
KO-539
KO539
Menin-Mixed Lineage Leukemia Protein-Protein Interaction Inhibitor KO 539
ziftomenib [INN]
ZIFTOMENIB [USAN]
Ziftomenib [WHO-DD]
Scientific Name
1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]-
4-Methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]-1H-indole-2-carbonitrile
(7S)-8⁴-(methanesulfonyl)-5⁴,7-dimethyl-1²-(methylamino)-1⁶-(2,2,2-trifluoroethyl)-2-aza-1(4)-thieno[2,3-d]pyrimidina-5(5,1)-indola-8(1)-piperazina-3(4,1)-piperidinaoctaphane-5²-carbonitrile
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | 4MOD1F4ENC |
Ziftomenib |
CAS: 2134675-36-6 INN: 11651 USAN: KL-149 SMS_ID: 300000020731 PUBCHEM: 138497449 FDA UNII: 4MOD1F4ENC NCI_THESAURUS: C164227 FDA ORPHAN DRUG: 697819 |
Record Info
| ID | BNKgERSnxG2Ly3MNvc3RZw |
|---|---|
| Created | April 10, 2026, 9:48 p.m. |
| Modified | April 10, 2026, 11:35 p.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |